Amicus Gets FDA Approval for Rare Muscle Disorder Treatment
BioSpace
SEPTEMBER 28, 2023
Thursday’s approval comes after the FDA pushed back the target action dates for Amicus’ Biologics License Application in May, allowing the regulator more time to review the company’s submitted data.
Let's personalize your content